Home›Search›GaBI Journal

GaBI Journal

Pro Pharma Communications International · Belgium · Est. 2012

ISSN2033-6403eISSN2033-6772

SJR Q3✓ WOS ESCI✓ Scopus / SJR

/ 100

High Risk

Score Breakdown

✓ WoS ESCI+10

✓ Scopus Q3+12

Total22

Journal Impact Factor

This journal is indexed in Web of Science (JCR) and has an official Journal Impact Factor. View the current value on the journal’s page ↗

SJR Score

0.15

H-Index

CiteScore

View ↗

Scopus metric · on the journal’s page

SNIP

0.31

Total Works

535

Total Citations

2,926

2yr Mean Citedness

0.53

Free JIF alternative

Aims & Scope✦ Inferred from recent articles

The journal focuses on biosimilars, including their uptake, policy measures, regulatory frameworks, and economic impact. It also covers aspects of biological medicines, generics, and pharmaceutical pricing. Research includes studies on handling and safety of specific biosimilar products, barriers to adoption in various countries, and the role of financing models and local production. The journal also addresses issues related to regulatory standards, interchangeability, and the environmental impact of drug development.

AI-summarised from recent articles · verify on publisher page →

⚡ Speed vs Prestige

How does this journal balance review speed with impact level?

SJR Rank

Top 75% in field

General Information

Country / RegionBelgium

Primary LanguageEnglish

1st Year Published2012

Annual Volume~ 27 articles / year

StatusActive (last: 2026)

Total Publications535

Visit Journal Website

Submission Info

Peer Review—

Review Time—

Acceptance Rate—

OA License—

OA Rate—

Ethics & Quality

COPE Member✗ No

OASPA Member✗ No

Not on Predatory Lists✓ Yes

Think.Check.Submit Compliance

thinkchecksubmit.org

6/12 · 50%

✅

Do you know the journal / publisher?

Pro Pharma Communications International

✅

Does the journal have a website?

✓ Linked

✅

Is the ISSN verified?

2033-6403 / 2033-6772

✅

Indexed in a trusted database?

Scopus

❌

Peer review process documented?

N/A

❌

Follows ethical publishing standards (COPE)?

N/A

❌

APC fees clearly disclosed?

N/A

✅

Not on predatory/blacklists?

✓ Clean

❌

Long-term digital preservation?

N/A

❌

Plagiarism detection in place?

N/A

❌

Listed in DOAJ (verified OA)?

N/A

✅

Primary language documented?

English

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Publication & Citation Trend

Articles published

Times cited

2019

2020

2021

2022

2023

2024

2025

2026

Source: OpenAlex · Note: citations accumulate over time so older years appear higher

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Drug GuidesQ3

PharmacyQ3

Subject Classification

Web of Science Categories

Pharmacology & Pharmacy

Scopus Categories

PharmacyDrug Guides

Research Topics (OpenAlex)

Biosimilars and Bioanalytical MethodsPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of LifePharmaceutical studies and practicesBiotechnology and Related FieldsScience, Research, and MedicineBiomedical Ethics and RegulationSafe Handling of Antineoplastic DrugsSemiconductor Quantum Structures and DevicesIntellectual Property and Patents